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Objectives: The preconditioning effects of the adjunctive, cardiac-specific sodium-
hydrogen ion exchange inhibitor cariporide (cariporide mesilate, HOE 642) were
studied in hearts subjected to 30 minutes of normothermic ischemia and reperfusion
to assess myocardial and endothelial changes.
Methods: Sixteen Yorkshire-Duroc pigs (27-34 kg) receiving cardiopulmonary
bypass underwent either cardiopulmonary bypass alone (control, n  4) or 30
minutes of normothermic ischemia, followed by 30 minutes of blood reperfusion
(n  12). Six hearts were treated with 5 mg/kg cariporide administered intrave-
nously 15 minutes before ischemia.
Results: Cardiopulmonary bypass alone caused no changes. Conversely, 30 minutes
of global normothermic ischemia caused 33% mortality and, in survivors, depres-
sion of left ventricular function to 22%  6% of baseline preload recruitable stroke
work and increased creatine kinase MB by 406% (88  13 U/L), conjugated dienes
by 17% (161 0.2 AU/mL), and myeloperoxidase activity by 297% (0.036 0.005
U/g). Myocardial edema developed (3.5% water gain). Coronary sinus endothelin 1
increased by 111% (2.05  0.38 pg/mL), and nitric oxide production decreased by
10%. These adverse effects were limited by pretreatment with cariporide, which
allowed complete survival and restored preload recruitable stroke work to 78% 
11%. Measurements of creatine kinase MB, conjugated dienes, myeloperoxidase,
water, and endothelin 1 returned to baseline values, and nitric oxide production was
accentuated 3-fold.
Conclusions: These observations show that adjunctive pretreatment with cariporide
delays myocardial and endothelial injury during ischemia and reperfusion, limits
oxygen-derived radical injury, restores function, reduces edema, and preserves
endothelin and nitric oxide balance at normal values. The myeloperoxidase changes
show that less white blood cell adherence supports reduced reperfusion endothelial
damage.
The hemodynamic consequence of ischemic damage followed bynormal blood reperfusion is closely related to that of calcium over-load. The resultant injury includes cell membrane damage, impairedendothelial function with endothelin release, and limited nitric oxide(NO) elaboration, resulting in leukocyte adherence, oxidant injury,and compromised pump function.
The genesis of reperfusion-related injury is linked to alteration of at least 3
calcium-related fundamental factors that include (1) the Na/H exchange mech-
anism, which is inactive during normal perfusion, but during ischemia extrudes pH
protons for sodium in an electron-neutral exchange that becomes the main buffering
system of the cell; (2) the adenosine triphosphate (ATP), energy-dependent sodium-
potassium exchange that extrudes sodium to prevent cellular overload; and (3) the
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energy-independent Na/Ca exchanger that normally ex-
trudes calcium to avoid intracellular overload. Prolonged
ischemia (5 minutes) accentuates acidosis and modifies
these protective factors by interfering with the ATP-depen-
dent sodium-potassium pump and activating the sodium-
hydrogen exchanger. The resultant sodium accumulation
allows subsequent calcium overload by means of unbridled
and now reversed activity of the sodium-calcium exchanger.
Calcium now enters the cell to reduce intracellular sodium
accumulation and accentuates damage.1 Secondary water
accumulation follows sodium overload, resulting in edema
that impairs compliance and restricts flow,2 ultimately con-
tributing to the death of myocytes that otherwise might have
survived reperfusion.
Prior studies have focused on calcium-channel blocking
agents that limit calcium entry at the membrane level with
drugs that might have adverse long-term effects (ie, nifed-
ipine). Novel management concepts have emerged after
recognition that inhibition of the Na/H ion exchange
mechanism can alter the pathophysiology of ischemia-
reperfusion injury. Pretreatment interference of Na/H ion
exchange activity will maintain intracellular acidosis and
thus limit sodium accumulation during the impaired activity
of the ATP-dependent sodium-potassium pump during the
ischemia-reperfusion interval. These have been isolated
studies1,3,4-7 rather than studies in the intact animal that
reflect the conditions relating to extracorporeal circulation
by using a model of a severely damaged heart for compar-
ison. The resultant reduced sodium accumulation restricts
the progressive detrimental activity of the sodium-calcium
exchanger. Cellular calcium overload is prevented until
more normal ion transfer mechanisms become restored dur-
ing the recovery phase of reperfusion.
The normal Na/H exchange function is most useful
during transient ischemia because controlling intracellular
pH will sustain contraction by maintaining electroneutral
exchange with hydrogen. Unfortunately, continuing activa-
tion during prolonged ischemia might cause calcium-related
hypercontracture if sodium can not be extruded during
reperfusion. Reversal of this energy-dependent impairment
does not occur immediately after reperfusion8 because the
operative adverse mechanism is ongoing depression of the
Na/K pump from impaired ATP genesis.9 This observa-
tion defines a paradox because Na/H exchange inhibi-
tion will maintain acidosis and is a marked contrast to
conventional efforts to rapidly reverse acidosis during the
immediate interval of reperfusion.
Cariporide (HOE 642) is a specific inhibitor of the
Na/H exchanger that delays myocardial damage1,3-5 and
reduces arrhythmias4,6,7 experimentally and lowers mortal-
ity and incidence of infarction in high-risk patients under-
going coronary artery bypass grafting.10 Intraoperative
myocardial protection methods (ie, cardioplegia) were ex-
tensively varied in this clinical report, so that direct quan-
tification of pretreatment capacity could not be established.
These early positive clinical benefits of Na/H exchange
inhibition set the stage for our study, which aims at evalu-
ating the pretreatment ability of the drug alone. Testing was
done in vulnerable hearts independent of adding the variable
of cardioplegic protection.
We selected an injury model that causes contractile and
endothelial dysfunction to simulate high-risk patients.11
This dual injury involves endothelin 1 (ET-1) release and
impaired NO production, with resultant vascular leukocyte
adherence and secondary cytotoxic oxygen radical produc-
tion.12,13 These vascular effects can compound contractile
dysfunction and should be offset by pretreatment. The
guidelines for Na/H inhibition success are improvement
of mechanical function, cellular and oxidant injury, leuko-
cyte adherence, and the vascular balance of endothelin and
NO levels.
Material and Methods
All animals received humane care in compliance with the “Prin-
ciples of Laboratory Animal Care” formulated by the Institute of
Laboratory Animal Resources and the “Guide for the Care and Use
of Laboratory” prepared by the National Institutes of Health (pub-
lication No. 86-23, revised 1985).
Sixteen Yorkshire-Duroc pigs (27-34.5 Kg) were premedicated
(15 mg/kg ketamine and 0.5 mg/kg diazepam administered intra-
muscularly), and anesthesia was achieved with 30 0.5 mg/kg
pentobarbital administered intravenously and subsequent bolus
injections of sodium pentobarbital. Support with a volume-con-
trolled ventilator (Servo 900C, Siemens-Elema) was started after
tracheostomy and endotracheal intubation. The femoral artery and
vein were cannulated, and arterial blood gases were measured to
maintain oxygen tension, carbon dioxide tension, and pH values
within the normal range. A balloon-tipped pulmonary artery cath-
eter (Model 132F5, Baxter Healthcare Corp) measured cardiac
output (thermodilution technique) and pulmonary artery pressure.
After a median sternotomy and pericardial incision, a solid-
state pressure transducer–tipped catheter (Model MPC-500, Millar
Instruments, Inc) was apically placed to monitor left ventricular
(LV) pressure. Left ventricle major and minor axes were measured
with endocardially placed 2-mm ultrasonic microtransducer crys-
tals (Sonometrics). LV volume was assessed by using an ellipsoid-
based formula. Pressure-volume loops were recorded digitally with
acquisition hardware and software (Sonometrics).
After systemic heparinization (300 U/kg), a 12F aortic cannula
was inserted in the ascending aorta, and a dual-lumen 29F venous
cannula was inserted in the right atrium through the right append-
age. Extracorporeal circulation with a membrane oxygenator (Af-
finity NT 541, Medtronic, Inc) and extracorporeal pump (Sarns)
included a circuit primed with 1000 mL of Plasma-Lyte solutions
(Baxter Healthcare Corp), 700 mL of stored porcine packed blood,
and calcium chloride for normocalcemia (1.0-1.2 mmol/L).
Cardiopulmonary bypass (CPB) was started at an oxygen ten-
sion of 300 mm Hg and an aortic pressure of 50 to 70 mm Hg,
adjusting flow to maintain approximately 70% mixed venous ox-
ygen saturation. Potassium, calcium, and pH were kept at normal
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levels. A dual-lumen aortic cannula in the aortic root measured
delivery of blood and aortic root pressure. Transatrial coronary
sinus cannulation allowed blood sampling, and the left ventricle
was vented. Rectal temperature was maintained at 35°C to 37°C
during extracorporeal circulation. All cases were performed and
analyzed by the same surgeon.
Experimental Protocol
Pigs were nonrandomly divided into 3 groups.
Nonischemic control hearts. The nonischemic control group
was composed of 4 piglets that underwent 60 minutes of normo-
thermic CPB to distinguish the effects of extracorporeal circulation
alone without ischemia.
Ischemic hearts. In 12 hearts ischemic damage was produced
by inducing 30 minutes of normothermic aortic clamping. Extra-
corporeal circulation was maintained for 30 minutes after un-
clamping and before measuring biochemistry and function.
In ischemic hearts without preconditioning (group 1), in 6
studies reperfusion was performed with normal blood from the
extracorporeal circuit. In ischemic hearts with preconditioning
(group 2), in 6 pigs 5 mg/kg cariporide (HOE 642) was added to
the extracorporeal circuit 15 minutes before inducing ischemia.
The cariporide half-life is 30 minutes, and therefore blockage of
the sodium-hydrogen exchanger was obtained with this dosage
regimen.
Mechanical Measurements
Global LV function before and 30 minutes after CPB was assessed
by means of Starling curves14 and pressure-volume analysis.15
Cardiac output was determined by using duplicate central venous
injections of 3 mL of 4°C saline solution, and the LV stroke work
index (LVSWI) was calculated by using the following formula:
LVSWI  (MAP  LAP)  CO  0.0136  HR1 Weight  1
where MAP indicates mean arterial pressure, LAP indicates left
auricular pressure, and HR indicates heart rate.
Modified Starling curves increased during preload conditions
by continuously infusing blood intravenously at 4 mL  kg1 
min1 during pacing at 150 beats/min during cardiac output.
Afterload was not controlled, but these transfusions simulated
clinical volume loading, with stroke work index analysis achieved
by recording cardiac output and blood pressure.
Pressure-volume curves evaluated cardiac performance with a
preload-, afterload-, and heart rate–independent method. Measure-
ments of LV pressure and volume were recorded during transient
inferior vena cava occlusions to obtain a series of evenly declining
pressure-volume loops. Global stroke work and end-diastolic vol-
ume were calculated with a video graphics program (SPECTRUM,
Triton Technology). Preload recruitable stroke work (PRSW) for
each series was identified as the relation between stroke work and
end-diastolic volume and quantified by using a slope and x-inter-
cept. The slope (erg  cm3  103 mW/cm3 of myocardium)
measures myocardial performance independent of loading, geom-
etry, and heart rate.16,17 Postbypass LV performance was ex-
pressed as a percentage of recovery from prebypass values.
Biochemical Analysis
Coronary sinus blood samples were taken 5 minutes after initiating
CPB (baseline) and 30 minutes after initiation of reperfusion. Both
samples were obtained in CPB to maintain the same degree of
hemodilution. During these measurements, coronary blood flow
was maintained at 100 mL/min (by using controlled aortic perfu-
sion with normal blood during transient aortic clamping) as plasma
samples were analyzed.
Conjugated dienes. As a marker of oxidant-mediated lipid
peroxidation, conjugated diene (CD) levels were determined spec-
trophotometrically after chloroform-methanol 2:1 (vol/vol) extrac-
tion, as previously described,18 and expressed as absorbance at a
wavelength of 240 nm per 0.5 mL of plasma.
Creatine kinase MB. Myocardial damage was determined by
measuring creatine kinase (CK) fraction MB (in units per liter)
with a UV-spectrophotometric method (Sigma Chemical Co), as
recommended by the German Society for Clinical Chemistry.
Nitric oxide. NO (in micromoles per liter) was determined as
its spontaneous oxidation products, nitrite and nitrate, which were
converted to NO and quantitated by using a Chemiluminescence
assay with a nitrogen oxide analyzer (Model 2108, DASIBI En-
vironmental Corp). We measured venous levels and compared
these over time. Our pilot studies showed no significant arterial-
venous gradient, probably because of negligible release.
Endothelin 1. ET-1 levels (in picograms per milliliter) were
determined after sample purification (Ethyl C2 Amprep minicol-
umns, Amersham Pharmacia Biotech) by using an Enzyme Immu-
nometric Assay (ACE EIA kit, Cayman Chemical Co) on the basis
of a double-antibody sandwich technique.
Myocardial Biopsy
Final measures of water content and myeloperoxidase activity
were made on hearts harvested after termination by means of bolus
injection of 5 mg of pentobarbital, followed a minute later by 15
mL of cold hyperkalemic blood (KCL, 30 mEq/L).
Myeloperoxidase activity. Transmural samples of the anterior
free wall of LV myocardium (approximately 0.5 g) were immedi-
ately frozen in liquid nitrogen, subsequently analyzed for neutro-
phil-specific myeloperoxidase activity, and expressed in units per
gram of tissue.19
Water content. Myocardial tissue was weighed before and
after incineration to determine the tissue percentage of water
content.
Statistical Analysis
Statistical analysis of data within and between groups was per-
formed by using multiple analysis of variance, followed by appli-
cation of the Student t test with the Tukey-Kramer correction for
multiplicity. All data are expressed as means  SD.
Results
LV Performance
Global volume loading of control hearts (without ischemic
damage) did not change the prebypass LVSWI after trans-
fusion to 15 mm Hg left atrial pressure, as seen in Figure 1.
In contrast, 2 ischemic hearts (without preconditioning)
could not sustain sufficient output to enable weaning from
extracorporeal circulation, and the other 4 pigs recovered
only 25%  5% of baseline LVSWI value. Pretreatment
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with cariporide allowed all piglets to be weaned from CPB,
with LVSWI recovery of 67%  11%.
There were no significant differences in baseline PRSW
values between groups (mean of all groups, 78  23 erg 
cm3  103). In control studies without ischemia, PRSW
returned to 105%  4% (99  37 erg  cm3  103) of
baseline values (Figure 2). In 4 of 6 survivors of ischemia
without pretreatment, PRSW returned to 22%  6% (19 
8 erg  cm3  103) of baseline values. Conversely, 6 of 6
cariporide pretreatment survivors recovered to 78%  11%
(57  15 erg  cm3  103) of baseline levels (P  .05).
Myocardial Damage
In nonischemic hearts CK-MB levels remained within the
normal range (25 U/L, Figure 3). Normothermic ischemia
without pretreatment increased the coronary sinus plasma
levels to 88  13 U/L, whereas pretreated CK-MB in-
creased to 42  4 U/L (P  .05).
CD levels remained within the normal range at 1.22 
0.02 AU/0.5 mL in control hearts. Ischemic injury (Figure
4) increased CDS to 1.61  0.15 AU/0.5 mL (P  .05 vs
control). Pretreatment with cariporide decreased CDS to
1.36  0.10 AU/0.5 mL, which was significantly less than
seen during ischemia without pretreatment.
Myeloperoxidase activity, marking white blood cell in-
jury (Figure 5), increased approximately 4-fold without
cariporide pretreatment. In contrast, pretreatment caused a
marginal augmentation versus control values (P  .05),
with values significantly less than those after ischemia with-
out cariporide (P  .05).
Extracorporeal circulation (Figure 6) caused an insignif-
icant increase in water content, whereas normothermic isch-
emia caused a marked increased to 82.3%  0.5% water
content (P  .05 vs bypass alone) that was prevented by
cariporide pretreatment (80.5%  0.5%, P  .05 vs isch-
emic group).
Endothelial Response
Extracorporeal circulation without ischemia caused a slight
increase in endothelin versus baseline values, as shown in
Figure 7. In contrast, ischemia doubled endothelin to 2.05
0.38 pg/mL, whereas cariporide pretreatment endothelin
values were similar to levels achieved with extracorporeal
circulation alone (1.22  0.15 vs 1.25  0.07 pg/mL).
NO levels after nonischemic CPB were similar to base-
line values (Figure 8) and were unchanged by ischemia.
Significant augmentation to 270%  173% followed cari-
poride pretreatment and produced higher levels than those
after ischemia (P .05), with moderate intergroup variabil-
ity.
Discussion
The endothelial and myocyte damage produced by 30 min-
utes of normothermic arrest includes leakage of CK-MB,
oxygen radical injury, water accumulation, endothelin re-
lease, and functional damage, followed by normal blood
supply replenishment. These adverse effects were substan-
tially limited by means of pretreatment with cariporide, an
Na/H exchange inhibitor.
We found that cariporide pretreatment (15 minutes be-
fore aortic clamping) diminished the mechanical effect of
profound ischemia-reperfusion injury because Starling
curves and PRSW (an index more independent of load, heart
rate, or geometry)16,17 showed marked recovery compared
with 33% mortality and profound depression in survivals
without pretreatment. The early maintenance of an acidotic,
rather than immediate, buffering to a normal pH level was
helpful and did not impair membrane function because less
Figure 1. Postischemic LV performance assessed by means of Starling curves. SWI, Stroke work index; LAP, left
atrial pressure.
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cytosolic enzymatic leakage of CK-MB occurred in the
pretreated group (P  .05) and phospholipid injury was
diminished.
Our model of ischemia-reperfusion damage might mirror
the vulnerability of high-risk patients who must undergo
CPB. Although this independent evaluation of pretreatment
interventions in injured hearts was introduced before adding
conventional myocardial protection studies (ie, hypothermia
and cardioplegia), subsequent studies must be done with the
aforementioned cardioplegic protection methods.
The Na/H exchanger is the natural system to extrude
protons out of the cell. It is activated by intracellular aci-
dosis and by various autocrine and paracrine factors, such as
ET-1, angiotensin II, 1-adrenergic agonists, and toxic
agents, such as hydrogen peroxide and lysophosphatidyl-
choline.20 Its activation during short periods of ischemia
(5 minute) allows continuing contraction by limiting an-
aerobic-induced lactacidosis. After prolonged ischemia,
contractility stops, and reperfusion damage becomes an
important pathophysiologic factor from intracellular Ca
overload.1-4,9 We ascribe the beneficial effects of Na/H
exchange blocker to limiting excessive Ca influx during
ischemia and reperfusion. This accumulation occurs after
Na overload, resulting from impaired capacity to exclude
sodium through ischemic damage of the ATP-dependant
sodium-potassium pump and the Na influx by the sodium-
hydrogen exchanger. Consequently, the energy-independent
Na/Ca pump becomes reversed because of a loss of
cohesion with the ATP-dependent means of extruding so-
dium, and calcium accumulates and can become massive.
These adverse events of ongoing activity of the Na/H
exchanger, responsible for Na influx, are implicated as the
mechanism of reperfusion injury in multiple experimental
studies.1,3,4 Conversely, inhibition of the exchanger by ca-
Figure 2. Recovery of PRSW expressed as a percentage of preischemic control values. Data are expressed as
means  SD. *P < .05 versus the control group and group 2; **P < .05 versus the control group and group 1.
Figure 3. Levels of CK-MB in units per liter from coronary sinus plasma at baseline and after 30 minutes of
reperfusion. Data are expressed as means  SD. *P < .05 versus group 2 and the control group.
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riporide during ischemia will attenuate intracellular accu-
mulation of Na and Ca in cardiomyocytes and diminish
rigor contracture during ischemia and reperfusion.4
The beneficial effects of cariporide during regional isch-
emia include reduction of infarct size,4,21 improved post-
myocardial infarction LV function,22 reduced apoptosis,23
reduced ATP preservation,24 and reduced auricular and ven-
tricular arrhythmias during reperfusion by reducing the re-
fractory period.6,7 In the surgical setting cariporide increases
tolerance to global ischemia and reperfusion,21 can be given
before ischemia, and might become more efficient than
ischemic preconditioning.25 Our surgical model differs from
regional ischemia by (1) controlling the interval of damage
(vs unstable angina or percutaneous transluminal coronary
angioplasty after myocardial infarction) and (2) recognizing
that subsequent added protective mechanisms (ie, hypother-
mia and cardioplegia) can be used during surgical repair.
The contractile recovery after Na/H exchange block-
ade (Figure 9) was associated with the secondary effects of
limiting reperfusion edema that might reflect less Na gain
after cariporide pretreatment. These mechanical effects of
the Na/H exchange blockade are well known, but novel
endothelial-related benefits (quantified by our measuring
NO and endothelin) might parallel reduced myocardial stun-
ning and edema and could expand how Na/H exchange
blockade alters ischemia-reperfusion damage.
Figure 4. Levels of CDS in coronary plasma expressed as absorbance units (A) per 0.5 mL at baseline and after 30
minutes of reperfusion. Data are expressed as means  SD. *P < .05 versus group 2 and the control group.
Figure 5. LV anterior free wall myocardial myeloperoxidase ac-
tivity taken at the end of the reperfusion period. Data are ex-
pressed as means  SD. *P < .05 versus group 2 and the control
group.
Figure 6. LV anterior free wall myocardial water content ex-
pressed as a percentage of weight taken at the end of the
reperfusion period. Data are expressed as means  SD. *P < .05
versus group 2 and the control group.
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The vascular endothelial-related injury might reflect an
improved balance between retained NO production capacity
to support vasodilatation (shown by the increase in NO
levels) and avoidance of increased endothelin production,
which enhances vasoconstriction. We cannot define pre-
cisely whether this was a predominant endothelial effect
because neither endothelium nor myocardium underwent
biopsy, and thus the evidence only suggests this relation-
ship. The Na/H blockade aided both factors in this en-
dothelin-NO relationship, but our observational studies did
not search for the responsible mechanisms. We believe that
the endothelial NO-endothelin relationship (a modular bal-
ance between vasodilatation and vasoconstriction) might
reflect a novel vascular harmony. A similar but recognized
relationship exists in myocytes, where the supply-demand
balance modulates normal muscle function under physio-
logic conditions.
The endothelial protection responsibilities of NO include
maintaining vascular dilatation, avoiding adhesion and ag-
gregation of platelets and neutrophils, promoting dissolu-
Figure 7. Levels of ET-1 from coronary sinus plasma at baseline
and after 30 minutes of reperfusion. Data are expressed as
means  SD. *P < .05 versus group 2 and the control group.
Figure 8. Change in NO production as a percentage from baseline
levels. Data are expressed as means SD. *P < .05 versus group
1.
Figure 9. Pressure-volume loops (above) and stroke work end-diastolic area (PRSWI) (below) in hearts under
baseline conditions (A), after ischemia (B), and after ischemia and pretreatment (C).
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tion of platelet aggregates, and secondarily preserving myo-
cardial mechanical and electrical activity.12,13,26 NO levels
were increased in pretreated hearts (Figure 8). The adverse
effects of postischemic endothelial cell dysfunction are also
associated with decreased endothelium-dependent vasodila-
tation and ET-1 elevation.27 ET-1 release produces reperfu-
sion endothelial-dependent vascular and nonvascular
smooth muscle contraction that exacerbates ischemic con-
tracture and direct myocardial death.27-29
Neutrophil activation worsens ischemia-reperfusion in-
jury because endothelial cells develop several binding neu-
trophil sites for attachment and penetration during reperfu-
sion,30 leading to obstruction of reflow and oxygen radical
damage. Myeloperoxidase activity reflects leukocyte accu-
mulation in the tissue assayed and was lower in treated
versus untreated hearts. This was associated with less lipid
peroxidation, which was assessed by measuring CDS. Such
pretreatment benefits differ from direct reperfusion tactics
that minimize deleterious effects of neutrophil activation by
using leukocyte depletion filters,31 by means of pharmaco-
logic alteration of leukocyte function,32 or by adding exog-
enous oxygen radical scavengers for evolved lipid peroxi-
dation products.33
Independent endothelin augmentation can unbalance the
NO-endothelin relationship and accentuate ischemia-reper-
fusion injury, even with normal NO production, and become
accentuated when NO production decreased.13 Our prior
studies suggest that NO synthesis is not impaired because
exogenous precursors for NO synthesis, such as L-arginine,
amplify coronary sinus NO levels.11
Cariporide preserves the balance between endothelin and
NO compared with that of untreated hearts, as shown in
Figures 7 and 8. This unanticipated limitation of endothelin
release might relate to the inhibitory effects of cariporide on
calcium concentration1 and emphasizes that Na/H ex-
change blockade might positively contribute to potential
recovery of both endothelium and muscle in the ischemia-
reperfusion injury process. The favorable vascular results of
pretreatment suggest that an anti-inflammatory action34
might supplement endothelial and myocardial effects.
We conclude that cariporide (1) delays direct myocardial
and endothelial injury in the ischemia-reperfusion model
when administered before the onset of ischemia and (2) also
might indirectly diminish myocardial and endothelial injury
by maintaining a more normal endothelin-NO balance, lim-
iting oxygen radical damage and endothelium leukocyte
binding and thereby protecting the endothelium, as well as
the myocytes. These pretreatment studies in the jeopardized
myocardium set the stage for future evaluation for pretreat-
ment of damage in preoperative high-risk ventricles that
must undergo more subsequent prolonged surgical aortic
clamping to repair the underlying defect.
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